Recipharm Monts Secures Regulatory Approval from ANSM to Fill Biotech Products
News Feb 04, 2013
Recipharm Monts has announced that it has secured authorization from the French health authorities (ANSM) to fill biotech products. Consequently, Recipharm is able to expand and diversify its combined offering.
The Monts site, which employs 200 personnel, comprises three filling lines. Two large capacity lines are used for glass vials for injection and a third one is an aseptic line that fills cartridges.
The timing of the new authorization coincides with the site installing a new, highly flexible vials line with multiple formats designed to handle smaller capacity orders.
The first production on this line, designed to fill both clinical and small commercial batches, will be readily available to the life science and pharmaceuticals market from mid 2013 onwards.
Michel Saudemon, General Manager at Recipharm Monts, commented: “We are delighted to have the opportunity to expand our sterile product manufacturing services with the authorized capability to fill biotech products.”
He added: “This regulatory approval, coming at a time when we have already set in place a programme of strategic expansion at the Monts site with the installation of a new service line, will serve to increase the range of sterile product manufacturing services that we can offer to the markets.”
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE